The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1176
https://www.valueinhealthjournal.com/article/S1098-3015(15)03252-0/fulltext
Title :
The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03252-0&doi=10.1016/j.jval.2015.09.1176
First page :
A458
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
680